The concept of vaccination failure

Vaccine

Volumn 30, Issue 7, 2012, Pages 1265-1268

  Heininger, U ^a   Bachtiar, N S ^b   Bahri, P ^c   Dana, A ^d   Dodoo, A ^e   Gidudu, J ^f   Santos, E M D ^g  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Bio Farma   (Indonesia)

^c EUROPEAN MEDICINES AGENCY   (United Kingdom)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF GHANA   (Ghana)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

AEFI (adverse events following immunization); Definition; Vaccination failure; Vaccine failure

Indexed keywords

ANTIGEN; MATERNAL ANTIBODY;

AGE; CONFIRMED CLINICAL VACCINE FAILURE; CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; DRUG MANUFACTURE; EXPIRATION DATE; HEALTH PROGRAM; HEALTH STATUS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INFECTION; MEDICATION ERROR; PATHOGENESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SENESCENCE; STORAGE; SUSPECTED CLINICAL VACCINE FAILURE; SUSPECTED IMMUNOLOGICAL VACCINE FAILURE; VACCINATION; VACCINE FAILURE;

ALGORITHMS; BACTERIAL INFECTIONS; DRUG STORAGE; HUMANS; IMMUNITY, INNATE; IMMUNIZATION SCHEDULE; PRACTICE GUIDELINES AS TOPIC; TREATMENT FAILURE; VACCINATION; VACCINES; VIRUS DISEASES;

EID: 84856575290     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.048     Document Type: Review

References (15)

1. Hinman A. Eradication of vaccine-preventable diseases. Annu Rev Public Health 1999, 20:211-229.
2. Hull H.F., Aylward R.B. Progress towards global polio eradication. Vaccine 2001, 19(31):4378-4384.
3. Davidkin I., Kontio M., Paunio M., Peltola H. MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines 2010, 9(9):1045-1053.
4. Obregón R., Chitnis K., Morry C., Feek W., Bates J., Galway M., et al. Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan. Bull World Health Organ 2009, 87(8):624-630.
5. Stehr K., Cherry J.D., Heininger U., Schmitt-Grohé S., überall M.A., Laussucq S., et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine or DT vaccine. Pediatrics 1998, 101:1-11.
6. Mangtani P., Mulholland K., Madhi S.A., Edmond K., O'Loughlin R., Hajjeh R. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines. Vaccine 2010, 28(7):1677-1683.
7. Muhsen K., Chodick G., Goren S., Shalev V., Cohen D. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community. Vaccine 2010, 29(1):91-94.
8. Beran J., Vesikari T., Wertzova V., Karvonen A., Honegr K., Lindblad N., et al. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. J Infect Dis 2009, 200(12):1861-1869.
9. De Villiers P.J., Steele A.D., Hiemstra L.A., Rappaport R., Dunning A.J., Gruber W.C., et al. Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older. Vaccine 2009, 28(1):228-234.
10. Paavonen J., Naud P., Salmerón J., Wheeler C.M., Chow S.N., Apter D., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374(9686):301-314.
11. Bejon P., Lusingu J., Olotu A., Leach A., Lievens M., Vekemans J., et al. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 2008, 359(24):2521-2532.
12. Spanjaard L., Rijkers G.T. Haemophilus influenzae serotype b vaccine failure: what is the significance of antibody levels?. Clin Infect Dis 2009, 49(3):381-382.
13. Huang M.L., Liao W.L., Ho M.S. HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure. Vaccine 2007, 25(34):6326-6333.
14. Andrews N., Borrow R., Miller E. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin Diagn Lab Immunol 2003, 10(5):780-786.
15. Cherry J.D., Gornbein J., Heininger U., Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998, 16:1901-1906.